Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Cash from Financing Activities (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Cash from Financing Activities for 16 consecutive years, with $3.4 million as the latest value for Q1 2025.

  • On a quarterly basis, Cash from Financing Activities rose 4150.92% to $3.4 million in Q1 2025 year-over-year; TTM through Sep 2025 was $5.0 million, a 2061.73% increase, with the full-year FY2024 number at $1.5 million, up 636.86% from a year prior.
  • Cash from Financing Activities was $3.4 million for Q1 2025 at Creative Medical Technology Holdings, up from $1.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $15.5 million in Q2 2022 to a low of -$191780.0 in Q3 2023.
  • A 5-year average of $2.5 million and a median of $105593.0 in 2021 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 14552.69% in 2022, then plummeted 1598266.67% in 2023.
  • Creative Medical Technology Holdings' Cash from Financing Activities stood at $9.3 million in 2021, then crashed by 100.0% to $12.0 in 2022, then plummeted by 659866.67% to -$79172.0 in 2023, then surged by 2158.18% to $1.6 million in 2024, then surged by 105.83% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Cash from Financing Activities are $3.4 million (Q1 2025), $1.6 million (Q4 2024), and -$25450.0 (Q3 2024).